Literature DB >> 19100362

Acute lymphoblastic leukemia: introduction.

Ching-Hon Pui1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19100362      PMCID： PMC2638983          DOI： 10.1053/j.seminhematol.2008.09.011

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  12 in total

Review 1.  Moving towards individualized medicine with pharmacogenomics.

Authors:  William E Evans; Mary V Relling
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

Review 2.  Acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; Mary V Relling; James R Downing
Journal:  N Engl J Med       Date:  2004-04-08       Impact factor: 91.245

Review 3.  Treatment of acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; William E Evans
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

Review 4.  Chromosomal abnormalities in cancer.

Authors:  Stefan Fröhling; Hartmut Döhner
Journal:  N Engl J Med       Date:  2008-08-14       Impact factor: 91.245

Review 5.  New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.

Authors:  Ching-Hon Pui; Sima Jeha
Journal:  Nat Rev Drug Discov       Date:  2007-02       Impact factor: 84.694

Review 6.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 7.  Acute lymphoblastic leukaemia.

Authors:  Ching-Hon Pui; Leslie L Robison; A Thomas Look
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

8.  In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.

Authors:  Christoph le Viseur; Marc Hotfilder; Simon Bomken; Kerrie Wilson; Silja Röttgers; André Schrauder; Annegret Rosemann; Julie Irving; Ronald W Stam; Leonard D Shultz; Jochen Harbott; Heribert Jürgens; Martin Schrappe; Rob Pieters; Josef Vormoor
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

Review 9.  Status of minimal residual disease testing in childhood haematological malignancies.

Authors:  Dario Campana
Journal:  Br J Haematol       Date:  2008-08-15       Impact factor: 6.998

10.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Authors:  Charles G Mullighan; Salil Goorha; Ina Radtke; Christopher B Miller; Elaine Coustan-Smith; James D Dalton; Kevin Girtman; Susan Mathew; Jing Ma; Stanley B Pounds; Xiaoping Su; Ching-Hon Pui; Mary V Relling; William E Evans; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2007-04-12       Impact factor: 49.962
View more
  15 in total

1.  Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.

Authors:  Donald M Lamkin; Erica K Sloan; Ami J Patel; Beverley S Chiang; Matthew A Pimentel; Jeffrey C Y Ma; Jesusa M Arevalo; Kouki Morizono; Steve W Cole
Journal:  Brain Behav Immun       Date:  2012-01-25       Impact factor: 7.217

2.  Asymptomatic leukemic-cell infiltration of the pancreas: US findings.

Authors:  Laura Collado; Esteban Dardanelli; Sergio Sierre; Silvia Moguillansky; José Lipsich
Journal:  Pediatr Radiol       Date:  2010-11-13

3.  Concurrent pancreatic and renal leukemic cell infiltration.

Authors:  Subramaniyan Ramanathan; Mahesh Prakash; Niranjan Khandelwal
Journal:  Indian J Hematol Blood Transfus       Date:  2013-03-07       Impact factor: 0.900

4.  A new, lineage specific, autoup-regulation mechanism for human glucocorticoid receptor gene expression in 697 pre-B-acute lymphoblastic leukemia cells.

Authors:  Chuan-dong Geng; Wayne V Vedeckis
Journal:  Mol Endocrinol       Date:  2010-11-17

5.  Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.

Authors:  Nina S Kadan-Lottick; Pim Brouwers; David Breiger; Thomas Kaleita; James Dziura; Veronika Northrup; Lu Chen; Megan Nicoletti; Bruce Bostrom; Linda Stork; Joseph P Neglia
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

6.  Signaling proteins and transcription factors in normal and malignant early B cell development.

Authors:  Patricia Pérez-Vera; Adriana Reyes-León; Ezequiel M Fuentes-Pananá
Journal:  Bone Marrow Res       Date:  2011-05-20

7.  Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of ex vivo treated pediatric T-cell acute lymphoblastic leukemia cells.

Authors:  Daniela Kuzilková; Cristina Bugarin; Katerina Rejlova; Axel R Schulz; Henrik E Mei; Maddalena Paganin; Alessandra Biffi; Andrea Biondi; Tomas Kalina; Giuseppe Gaipa
Journal:  Haematologica       Date:  2022-06-01       Impact factor: 11.047

8.  Differential mRNA expression levels of human histone-modifying enzymes in normal karyotype B cell pediatric acute lymphoblastic leukemia.

Authors:  Yan-Fang Tao; Li Pang; Xiao-Juan Du; Li-Chao Sun; Shao-Yan Hu; Jun Lu; Lan Cao; Wen-Li Zhao; Xing Feng; Jian Wang; Dong Wu; Na Wang; Jian Ni; Jian Pan
Journal:  Int J Mol Sci       Date:  2013-02-06       Impact factor: 5.923

9.  Association between the polymorphism rs3217927 of CCND2 and the risk of childhood acute lymphoblastic leukemia in a Chinese population.

Authors:  Heng Zhang; Yan Zhou; Yaoyao Rui; Yaping Wang; Jie Li; Liuchen Rong; Meilin Wang; Na Tong; Zhengdong Zhang; Jing Chen; Yongjun Fang
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

10.  Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL.

Authors:  Marie Loosveld; Rémy Castellano; Stéphanie Gon; Armelle Goubard; Thomas Crouzet; Laurent Pouyet; Thomas Prebet; Norbert Vey; Bertrand Nadel; Yves Collette; Dominique Payet-Bornet
Journal:  Oncotarget       Date:  2014-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.